Clinical Trial Update: Interest of Measuring P2X4 Receptors on Blood Monocytes as a Diagnostic Marker in Amyotrophic Lateral Sclerosis: P2X4 as a Diagnostic Biomarker for ALS [NA]

View source ↗

Summary

This ongoing clinical trial investigates whether measuring P2X4 receptor expression on blood monocytes can diagnose amyotrophic lateral sclerosis, and it is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Amyotrophic Lateral Sclerosis &Amp; Other Neuromuscular Disorders | NA | Status: RECRUITING